Elevated Homocysteine: Causes, Symptoms, and Treatment

Elevated homocysteine, a condition doctors call hyperhomocysteinemia, is linked to a higher risk of heart disease, stroke, blood clots, cognitive decline, and pregnancy complications. Homocysteine itself is a normal amino acid produced when your body processes methionine, a building block of protein found in meat, eggs, dairy, and other foods. Trouble starts when homocysteine accumulates in the blood instead of being recycled or cleared, usually because B vitamins are in short supply, a genetic variant slows the recycling machinery, or both. What makes this topic genuinely interesting is the gap between the clear observational evidence connecting high homocysteine to disease and the disappointing results of trials that lower it with supplements.

Where Homocysteine Comes From

Methionine is an essential amino acid you get from food. Your body uses it for dozens of chemical reactions, and homocysteine is a natural byproduct of that process. Normally, homocysteine gets recycled back into methionine (a step that requires folate and vitamin B12) or converted into cysteine (a step that requires vitamin B6). When either pathway stalls, homocysteine builds up in the bloodstream.¹ Most labs consider a fasting plasma level above about 15 µmol/L to be elevated, though some researchers flag anything above 11 µmol/L in older adults as worth monitoring.

The Main Causes

B Vitamin Deficiencies

The single most common reason for elevated homocysteine is not getting enough folate, vitamin B12, or vitamin B6. Of the three, folate and B12 matter most because they directly feed the enzyme that converts homocysteine back to methionine. People who eat few leafy greens, legumes, or fortified grains tend to have lower folate levels. Strict vegans are at particular risk of B12 deficiency since B12 is found almost exclusively in animal products. Older adults also absorb B12 less efficiently from food, making deficiency more common with age. Supplementing with folic acid and B12 is the standard approach to correcting homocysteine levels tied to nutritional shortfalls, and folic acid fortification of grain products (mandatory in many countries) was originally aimed at preventing neural tube defects but also helps keep homocysteine in check at the population level.²

Genetic Variants, Especially MTHFR

Your genes can make you more vulnerable. The most studied variant involves a gene called MTHFR, which produces an enzyme needed to activate folate into its usable form. People who carry two copies of the C677T variant (the TT genotype) have a substantially less efficient enzyme, and their odds of developing high homocysteine are roughly ten times greater than those with the normal CC genotype.³ Other gene variants in the methionine synthase (MS) and cystathionine beta-synthase (CBS) pathways also influence levels, and their effects are additive, meaning carrying unfavorable variants in more than one gene compounds the problem. The MTHFR TT genotype is relatively common in some populations, affecting up to 10–15% of people of European or East Asian descent, which is part of why elevated homocysteine is so widespread.

Carriers of the MTHFR T allele who also have hypertension tend to have even higher homocysteine levels than carriers without hypertension, a combination sometimes called “H-type hypertension” in the medical literature.⁴

Medications and Medical Conditions

A number of widely prescribed drugs raise homocysteine. These include certain cholesterol-lowering medications like fibrates and niacin, the diabetes drug metformin, some anti-seizure medications, and drugs used for rheumatoid arthritis. Many of these seem to interfere with folate or B vitamin metabolism, though the exact mechanism is not always clear.⁵ Kidney disease is another major contributor because the kidneys help clear homocysteine from the blood; when they are not working well, levels climb. Hypothyroidism and some cancers can also push homocysteine up.

How Elevated Homocysteine Damages the Body

Homocysteine at high concentrations injures the endothelium, the thin layer of cells lining your blood vessels. It does this through several overlapping mechanisms: triggering inflammation, generating damaging reactive oxygen species, reducing the availability of nitric oxide (the molecule that keeps arteries relaxed and flexible), and promoting abnormal growth of smooth muscle cells in artery walls.⁶ A newer line of research has also identified “protein homocysteinylation,” where homocysteine chemically attaches to proteins and alters their function, as an additional route of damage both inside and outside cells.⁷

The net effect is that arteries become stiffer, more prone to plaque buildup, and more likely to form clots. Evidence from both retrospective and prospective studies supports the link between higher homocysteine and increased risk of coronary artery disease, stroke, and venous blood clots.⁸ Hyperhomocysteinemia is recognized as an independent risk factor for vascular events, and keeping plasma levels below about 50 µmol/L is considered important for reducing the risk of thrombotic complications in people with significantly elevated values.⁹

The Cognitive Connection

One of the more compelling areas of homocysteine research involves the brain. An international consensus statement concluded that moderately elevated homocysteine (above about 11 µmol/L, which is common in older adults) is a modifiable risk factor for cognitive decline, dementia, and Alzheimer’s disease. The relative risk of dementia in elderly people with modestly raised levels ranges from about 1.15 to 2.5 depending on the study, meaning the increase in risk is real but variable.¹⁰ That same consensus found that B vitamin treatment slowed brain atrophy and cognitive decline in intervention trials involving elderly people who already had some cognitive impairment.

A more recent study reinforced this, finding that people with mild cognitive impairment whose homocysteine fell in the highest third of the distribution had more than double the risk of progressing to full dementia compared to those in the lowest third.¹¹ This makes homocysteine one of the few blood markers that may help identify people on a trajectory toward dementia early enough to intervene.

Pregnancy Risks

High homocysteine during pregnancy is associated with a range of serious complications, including recurrent miscarriage, preeclampsia, placental abruption, fetal growth restriction, and preterm delivery.¹² These complications appear to stem from damage to the blood vessels that supply the placenta. There is also evidence of a negative correlation between maternal homocysteine levels and neonatal birth weight.¹³ High homocysteine may additionally affect fertility itself, increasing the risk of infertility and miscarriage in women undergoing IVF.¹⁴

This is one reason prenatal folic acid supplementation is so strongly recommended. It addresses two problems at once: preventing neural tube defects and keeping homocysteine from spiking during a period when the mother’s vascular system is under extra strain.

Effects on Bone and Eyes

Homocysteine’s reach extends beyond the blood vessels. In bone, high levels disrupt collagen cross-linking, increase oxidative stress, and lead to accumulation of compounds that weaken bone structure. The result is reduced bone mass and impaired bone quality, a combination that goes beyond what a standard bone density scan would reveal.¹⁵ Animal studies show that experimentally induced high homocysteine caused a dramatic accumulation of the amino acid in bone tissue (roughly 13 to 20 times normal), with most of it bound to collagen, and led to significant losses in cancellous bone and reductions in bone strength.¹⁶

In the eyes, elevated homocysteine has been linked to several conditions, including the wet form of age-related macular degeneration, glaucoma, cataracts, retinal vessel disease, and optic atrophy.¹⁷ One study found an association specifically with the neovascular (wet) form of macular degeneration but not the dry form, suggesting the vascular-damaging effects of homocysteine may be the mechanism at play.¹⁸

Treatment With B Vitamins

The good news is that elevated homocysteine responds well to supplementation. A meta-analysis of randomized trials found that folic acid alone reduces blood homocysteine by about 25%, and adding vitamin B12 brings the total reduction to roughly a quarter to a third. Doses of folic acid between 0.5 and 5 mg daily were similarly effective, meaning you do not necessarily need a high dose. Vitamin B6 did not add a significant further reduction on top of folate and B12.¹⁹ A trial in coronary artery disease patients confirmed that even a low dose of 400 micrograms of folic acid daily, combined with B12 and B6, lowered homocysteine from about 14 to about 10 µmol/L, and higher folic acid doses did not produce meaningfully bigger drops.²⁰

In people with mild cognitive impairment, B vitamin supplementation produced an average homocysteine reduction of about 32%, with statistically significant declines visible after just one month.²¹ So there is no real question about whether B vitamins lower homocysteine. They do, reliably and quickly.

The Treatment Paradox

Here is where the story gets frustrating. Despite the consistent observational evidence linking high homocysteine to cardiovascular disease, the major clinical trials that lowered homocysteine with B vitamins did not see a corresponding drop in heart attacks, strokes, or deaths. The landmark HOPE-2 trial found that active treatment lowered homocysteine meaningfully compared to placebo, yet the rates of major cardiovascular events were nearly identical between the two groups.²² A large Cochrane review pooling data from multiple trials confirmed this pattern: homocysteine-lowering treatments made no difference to heart attacks, death from any cause, or serious adverse events compared to placebo.²³

Another Norwegian trial, WENBIT, saw a 30% drop in homocysteine levels in the treatment group but no benefit for its composite endpoint of death, heart attack, unstable angina, or stroke. In fact, the group receiving folic acid had a slightly (non-significantly) higher event rate than the group that did not.²⁴

What does this mean? There are a few interpretations. One possibility is that homocysteine is a marker of underlying problems (poor nutrition, kidney dysfunction, genetic factors) rather than a direct cause of heart disease. In that case, lowering the number without fixing the root cause would not help. Another is that the damage from years of elevated homocysteine is already done by the time you intervene, especially since most trial participants were older adults who had already developed vascular disease. A third possibility is that homocysteine does cause harm, but B vitamins correct only the level, not the downstream damage. The honest answer is that nobody has fully resolved this paradox, and it remains one of the more debated questions in cardiovascular medicine.

The cognitive domain is a different story. As mentioned earlier, B vitamin trials in people with cognitive impairment have shown slower brain shrinkage and cognitive decline, suggesting that for the brain, lowering homocysteine may genuinely help, even if the cardiovascular results have been disappointing.

Beyond B Vitamins

Betaine, a nutrient found in beets, spinach, quinoa, and wheat germ, provides an alternative route for recycling homocysteine back to methionine. A meta-analysis found that supplementing with at least 4 grams per day of betaine for a minimum of six weeks lowers plasma homocysteine by about 1.2 µmol/L in healthy adults, a modest but consistent effect.²⁵ Combining low-dose B vitamins with betaine may be more effective than either alone; a clinical trial in Chinese adults with high homocysteine found that the combination reduced levels by about 10% over 12 weeks.²⁶

For people with classical homocystinuria, a rare inherited disorder that causes extremely high levels, treatment often involves a low-methionine diet (since methionine is the precursor to homocysteine), B6 supplementation if the patient responds to it, and betaine paired with B12 for those who do not respond to B6 alone.²⁷

Getting Your Test Right

If you are going to test your homocysteine, the sample handling matters more than most people realize. Homocysteine continues to leak out of red blood cells after blood is drawn, so if the plasma is not separated from the cells within about 30 minutes, levels rise by roughly 10% per hour. Given that the difference between “normal” and “elevated” can be just a few µmol/L, a blood sample that sits at room temperature in a clinic waiting for transport to a lab can easily produce a falsely high reading.²⁸ If your result comes back borderline high, it is reasonable to ask whether the sample was processed quickly or to repeat the test under better conditions before starting treatment.

Emerging Research on Gut Bacteria

An intriguing new direction involves the gut microbiome. Certain probiotic bacteria can produce bioactive forms of folate, and in animal models, a high-dose cocktail of folate-producing probiotic strains raised serum folate and lowered homocysteine in deficient mice. The probiotic treatment also shifted gut bacterial communities toward potentially beneficial species.²⁹ This is still early-stage work and a long way from clinical recommendations, but it raises the possibility that in the future, managing homocysteine could involve optimizing gut health alongside traditional vitamin supplementation. For now, the evidence-backed tools remain B vitamins, betaine, and in severe cases, dietary methionine restriction and specialized medical care.